Nausea (on GLP-1 Therapy)
The most common GLP-1 side effect — front-loaded to dose changes, manageable, and usually temporary.
Nausea leads every GLP-1 adverse-event table because the therapeutic mechanism — slowed gastric emptying, amplified fullness signaling — overshoots while the body adapts. It clusters around starting doses and each escalation step, then typically fades over days to weeks; a minority find it persistent enough to cap their dose or switch drugs.
Management is well-worn: smaller meals eaten slowly, stopping at satisfied rather than full, limiting greasy and very sweet food, hydration, and not lying down after eating. Prescribers can slow the escalation schedule or add an anti-nausea medication like ondansetron. The reporting threshold: vomiting that prevents fluids, or severe pain, is no longer "expected nausea" — message your doctor.
This glossary entry is general information, not medical advice, and is written to be consistent with FDA prescribing information and primary trial publications as of its last review. Always consult a licensed healthcare provider for personal medical decisions.
Questions about Nausea? Ask a doctor free.
A licensed doctor can apply this to your health history in a free telehealth consultation — booking takes about two minutes, with programs from $149/month. You're only charged after approval.
Book an Appointment